This site is intended for healthcare professionals
Guidelines
  • Home
  • /
  • Guidelines
  • /
  • Breast Cancer
  • /
  • Risk reduction and screening of cancer in heredita...
Guideline

Risk reduction and screening of cancer in hereditary breast-ovarian cancer syndromes: ESMO Clinical Practice Guideline

Read time: 1 mins
Last updated:1st Jan 2023
Availability: Free Full Text
Status: Live
Risk reduction and screening of cancer in hereditary breast-ovarian cancer syndromes: ESMO Clinical Practice Guideline - European Society for Medical Oncology (ESMO)


This guideline provides recommendations for risk-reduction and screening for individuals with a hereditary breast and ovarian cancer syndrome.

This guideline focuses on risk-reduction and screening mainly in unaffected carriers and particularly in high-resource settings.

The panel encompasses an international multidisciplinary group of experts.

Recommendations are based on available scientific data and the authors’ collective expert opinion.


Read full Guideline